Trials / Completed
CompletedNCT00620464
A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)
A Randomized, Double-Blind, Parallel Group, Bioequivalence Study of IMPLANON and Radiopaque IMPLANON
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to demonstrate the bioequivalence of IMPLANON and Radiopaque IMPLANON.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Radiopaque Implanon | Radiopaque rod for 3 years |
| DRUG | Implanon (etonogestrel implant) | Implanon (etonogestrel implant) for 3 years |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-02-21
- Last updated
- 2022-02-04
- Results posted
- 2010-05-17
Source: ClinicalTrials.gov record NCT00620464. Inclusion in this directory is not an endorsement.